Product Name

  • Name

    Imipramine hydrochloride

  • EINECS 204-030-7
  • CAS No. 113-52-0
  • Article Data1
  • CAS DataBase
  • Density 1.041g/cm3
  • Solubility Soluble in water
  • Melting Point 168-170 °C
  • Formula C19H25ClN2
  • Boiling Point 403.1 °C at 760 mmHg
  • Molecular Weight 316.874
  • Flash Point 179.7 °C
  • Transport Information White solid
  • Appearance UN 1230 3/PG 2
  • Safety 7-16-24-33-45-36-26
  • Risk Codes 23/25-36/38-36/37/38-22
  • Molecular Structure Molecular Structure of 113-52-0 (Imipramine hydrochloride)
  • Hazard Symbols HarmfulXn
  • Synonyms N-(g-Dimethylaminopropyl)iminodibenzyl hydrochloride;Praminil;Presamine;Promiben;SK-Pramine;Surplix;Tipramine;Tofranil;Tofranile;5H-Dibenz[b,f]azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-, monohydrochloride (8CI);Eupramin;Feinalmin;Imavate;Imidol;Imilanyle;Imipramine monohydrochloride;Imiprin;Imizinum;Iramil;Chrytemin;Censtim;Censtin;Apo-Imipramine;5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenz[b,f]azepine hydrochloride;Dyna-Zina;N-(3-Dimethylaminopropyl)iminodibenzylhydrochloride;Melipramine hydrochloride;
  • PSA 6.48000
  • LogP 4.74200

Synthetic route

Reaxys ID: 19040915

Reaxys ID: 19040915

Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

Conditions
ConditionsYield
Stage #1: In acetone for 0.5h; Heating / reflux;
Stage #2: In di-isopropyl ether at 0 - 5℃;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

water
7732-18-5

water

potassium hexacyanoferrate(III)

potassium hexacyanoferrate(III)

imipraminium ferricyanide monohydrate

imipraminium ferricyanide monohydrate

Conditions
ConditionsYield
In water E-2 M solns. were mixed; ppt. was filtered, thoroughly washed with distd. water, dried at room temp., elem. anal.;99.5%
sodium hexanitro cobaltate(III)

sodium hexanitro cobaltate(III)

Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

water
7732-18-5

water

imipraminium cobaltnitrite monohydrate

imipraminium cobaltnitrite monohydrate

Conditions
ConditionsYield
In water E-2 M solns. were mixed; ppt. was filtered, thoroughly washed with distd. water, dried at room temp., elem. anal.;99.5%
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

sodium salicylate
54-21-7

sodium salicylate

imipramine salicylate
1085510-17-3

imipramine salicylate

Conditions
ConditionsYield
In water at 20 - 62℃; for 19.95h;95.1%
In water at 20 - 62℃; for 19.95h;95.1%
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

2-Formylimipramine
6487-79-2

2-Formylimipramine

Conditions
ConditionsYield
With trichlorophosphate at 100℃; for 4h; Formylation; Vilsmeier Reaction;59%
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

[3-(2-{Bis-[5-(3-dimethylamino-propyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-2-yl]-methyl}-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-dimethyl-amine
129961-34-8

[3-(2-{Bis-[5-(3-dimethylamino-propyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-2-yl]-methyl}-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-dimethyl-amine

Conditions
ConditionsYield
With tetrafluoroboric acid diethyl ether In diethyl ether; dichloromethane for 6h; Ambient temperature;8%
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

C

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

Conditions
ConditionsYield
In water Ambient temperature; M. griseo-cyanus (ATCC 1207a); further microbial agents;A 10 mg
B n/a
C n/a
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

C

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

D

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

Conditions
ConditionsYield
In water for 480h; Ambient temperature; C. blakesleeana (ATCC 8688a); further microbial agents; Further byproducts given;A n/a
B n/a
C 30 mg
D 88 mg
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

10-Hydroxyimipramine
796-28-1

10-Hydroxyimipramine

C

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

D

imipramine N-oxide
6829-98-7

imipramine N-oxide

Conditions
ConditionsYield
In water; N,N-dimethyl-formamide for 480h; Ambient temperature; C. blakesleeana (ATCC 8688a); further microbial agents; Further byproducts given;A n/a
B 30 mg
C 88 mg
D n/a
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

imipramine N-oxide
6829-98-7

imipramine N-oxide

Conditions
ConditionsYield
In water; N,N-dimethyl-formamide for 360h; Ambient temperature; F. oxysporum f. sp. cepae (ATCC 11711); further microbial agents;A 7 mg
B n/a
In water for 312h; Ambient temperature; A. flavipes (ATCC 16795); further microbial agents;A n/a
B 112 mg
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

C19H20(2)H4N2*ClH
61361-33-9

C19H20(2)H4N2*ClH

Conditions
ConditionsYield
With deuteroacetic acid; sulfuric acid-d2 at 100℃; for 1.5h; in sealed tube; Yield given;
pyrocatechol violet

pyrocatechol violet

Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

2-{(3,4-Dihydroxy-phenyl)-[3-hydroxy-4-oxo-cyclohexa-2,5-dien-(E)-ylidene]-methyl}-benzenesulfonic acid; compound with [3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-dimethyl-amine

2-{(3,4-Dihydroxy-phenyl)-[3-hydroxy-4-oxo-cyclohexa-2,5-dien-(E)-ylidene]-methyl}-benzenesulfonic acid; compound with [3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-dimethyl-amine

Conditions
ConditionsYield
With sulfuric acid
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

C38H48N4*2H(1+)

C38H48N4*2H(1+)

Conditions
ConditionsYield
With iron(III) chloride; acetic acid at 75℃; for 0.0833333h;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

B

Dimethyl-propylidene-ammonium

Dimethyl-propylidene-ammonium

Conditions
ConditionsYield
at 280 - 326℃; Kinetics;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

desipramine
50-47-5

desipramine

B

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

Conditions
ConditionsYield
With NADP; cDNA-expressed human recombinant CYP1A2 In phosphate buffer at 37℃; for 0.25h; pH=7.4; Enzyme kinetics; Further Variations:; concentration;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 59 percent / POCl3 / 4 h / 100 °C
2: m-CPBA; TFA / CH2Cl2 / 2 h / 5 - 20 °C
3: conc. HCl / methanol / 2 h
View Scheme
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

formic acid 5-(3-dimethylamino-propyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-2-yl ester
134150-88-2

formic acid 5-(3-dimethylamino-propyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-2-yl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 59 percent / POCl3 / 4 h / 100 °C
2: m-CPBA; TFA / CH2Cl2 / 2 h / 5 - 20 °C
View Scheme
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

3-Hydroxy-2-naphthoic acid
92-70-6

3-Hydroxy-2-naphthoic acid

imipramine xinafoate
1085510-09-3

imipramine xinafoate

Conditions
ConditionsYield
In water at 25 - 50℃; for 20h;
disodium pamoate

disodium pamoate

Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

imipramine pamoate

imipramine pamoate

Conditions
ConditionsYield
Stage #1: disodium pamoate; Imipramine hydrochloride In water; acetone at 20 - 55℃;
Stage #2: In water at 40 - 70℃;
In water at 5℃;
impramine
50-49-7

impramine

Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

embonic acid disodium salt
6640-22-8, 7681-47-2, 15537-67-4

embonic acid disodium salt

imipramine pamoate
10075-24-8

imipramine pamoate

Conditions
ConditionsYield
With sodium hydroxide In water
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
With peroxidase from horseradish type VI; dihydrogen peroxide at 37℃; for 1h; pH=7; aq. phosphate buffer; Enzymatic reaction;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

imipramine hydrochloride di-zinc chloride

imipramine hydrochloride di-zinc chloride

Conditions
ConditionsYield
With zinc(II) chloride at 60 - 100℃; for 24h; Inert atmosphere; Sealed tube;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

A

2-hydroxyimipramine
303-70-8

2-hydroxyimipramine

B

4-hydroxyimipramine
94436-87-0

4-hydroxyimipramine

C

1-hydroxyimipramine

1-hydroxyimipramine

D

3-hydroxyimipramine

3-hydroxyimipramine

Conditions
ConditionsYield
With NADP+; D-glucose-6- In aq. phosphate buffer; dimethyl sulfoxide at 37℃; for 1h; pH=7.4; Enzymatic reaction;
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

2-hydroxynaphthalene-3-carboxylic acid sodium salt
14206-62-3, 37626-26-9, 40858-57-9, 85750-03-4

2-hydroxynaphthalene-3-carboxylic acid sodium salt

imipramine xinafoate

imipramine xinafoate

Conditions
ConditionsYield
In water at 50℃; for 20h;12.7 g
Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

impramine
50-49-7

impramine

Conditions
ConditionsYield
With sodium hydroxide In water
C62H68N16O24S4(4-)*4Na(1+)

C62H68N16O24S4(4-)*4Na(1+)

Imipramine hydrochloride
113-52-0

Imipramine hydrochloride

C19H24N2*ClH*C62H68N16O24S4(4-)*4Na(1+)

C19H24N2*ClH*C62H68N16O24S4(4-)*4Na(1+)

Conditions
ConditionsYield
In aq. phosphate buffer pH=7.4; UV-irradiation;

Imipraminehydrochloride Toxicity Data With Reference

1.   

dni-oin-unr 10 g/L

   JCLBA3    Journal of Cell Biology. 47 (1970),182a.
2.   

cyt-oin-unr 10 g/L

   JCLBA3    Journal of Cell Biology. 47 (1970),182a.
3.   

orl-man TDLo:2143 µg/kg/2D-I

   JCLPDE    Journal of Clinical Psychiatry. 44 (1983),225.
4.   

orl-chd TDLo:25 mg/kg:CNS,PUL

   JAMAAP    JAMA, Journal of the American Medical Association. 179 (1962),456.
5.   

orl-chd LDLo:15 mg/kg

   BMJOAE    British Medical Journal. 1 (1974),261.
6.   

orl-chd TDLo:27 mg/kg:CNS,KID

   JAMAAP    JAMA, Journal of the American Medical Association. 230 (1974),1405.
7.   

orl-wmn TDLo:107 mg/kg:CNS,CVS

   NEJMAG    New England Journal of Medicine. 268 (1963),33.
8.   

orl-wmn TDLo:30 mg/kg:PNS,CNS

   BMJOAE    British Medical Journal. 2 (1959),1458.
9.   

orl-rat LD50:305 mg/kg

   TXAPA9    Toxicology and Applied Pharmacology. 18 (1971),185.
10.   

ipr-rat LD50:72 mg/kg

   ARZNAD    Arzneimittel-Forschung. Drug Research. 21 (1971),391.
11.  &nb

Imipraminehydrochloride Consensus Reports

Reported in EPA TSCA Inventory.

Imipraminehydrochloride Safety Profile

Human poison by ingestion. An experimental poison by ingestion, intravenous, subcutaneous, and intraperitoneal routes. An experimental teratogen. Human systemic effects by ingestion: sleep, somnolence, convulsions, muscle contraction or spasticity, coma, blood pressure decrease, dyspnea (difficulty in breathing), paresthesia (abnormal sensations), and kidney changes. Experimental reproductive effects. Mutation data reported. Used in the treatment of depression. When heated to decomposition it emits very toxic fumes of NOx and HCl. See also DIAZEPAM.
Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View